Feline Injection-Site Sarcoma and Other Adverse Reactions to Vaccination in Cats
Katrin Hartmann,
Herman Egberink,
Karin Möstl,
Diane D. Addie,
Sándor Belák,
Corine Boucraut-Baralon,
Tadeusz Frymus,
Albert Lloret,
Regina Hofmann-Lehmann,
Fulvio Marsilio,
Maria Grazia Pennisi,
Séverine Tasker,
Etienne Thiry,
Uwe Truyen,
Margaret J. Hosie
Affiliations
Katrin Hartmann
Small Animal Clinic, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany
Herman Egberink
Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, University of Utrecht, 3584 CL Utrecht, The Netherlands
Karin Möstl
Institute of Virology, Department for Pathobiology, University of Veterinary Medicine, 1210 Vienna, Austria
Diane D. Addie
Maison Zabal, 64470 Etchebar, France
Sándor Belák
Department of Biomedical Sciences and Veterinary Public Health (BVF), Swedish University of Agricultural Sciences (SLU), P.O. Box 7036, 750 07 Uppsala, Sweden
Corine Boucraut-Baralon
Scanelis Veterinary Test Laboratory, 31770 Colomiers, France
Tadeusz Frymus
Department of Small Animal Diseases with Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences—SGGW, 02-787 Warsaw, Poland
Clinical Laboratory, Department of Clinical Diagnostics and Services, Vetsuisse Faculty, University of Zuich, 8057 Zurich, Switzerland
Fulvio Marsilio
Faculty of Veterinary Medicine, Università degli Studi di Teramo, 64100 Teramo, Italy
Maria Grazia Pennisi
Dipartimento di Scienze Veterinarie, Università di Messina, 98168 Messina, Italy
Séverine Tasker
Bristol Veterinary School, University of Bristol, Bristol BS40 5DU, UK
Etienne Thiry
Veterinary Virology and Animal Viral Diseases, Department of Infectious and Parasitic Diseases, FARAH Research Centre, Faculty of Veterinary Medicine, Liège University, B-4000 Liège, Belgium
Uwe Truyen
Institute of Animal Hygiene and Veterinary Public Health, University of Leipzig, 04103 Leipzig, Germany
Margaret J. Hosie
MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK
Vaccine-associated adverse events (VAAEs), including feline injection-site sarcomas (FISSs), occur only rarely but can be severe. Understanding potential VAAEs is an important part of informed owner consent for vaccination. In this review, the European Advisory Board on Cat Diseases (ABCD), a scientifically independent board of feline medicine experts, presents the current knowledge on VAAEs in cats, summarizing the literature and filling the gaps where scientific studies are missing with expert opinion to assist veterinarians in adopting the best vaccination practice. VAAEs are caused by an aberrant innate or adaptive immune reaction, excessive local reactions at the inoculation site, an error in administration, or failure in the manufacturing process. FISS, the most severe VAAE, can develop after vaccinations or injection of other substances. Although the most widely accepted hypothesis is that chronic inflammation triggers malignant transformation, the pathogenesis of FISS is not yet fully understood. No injectable vaccine is risk-free, and therefore, vaccination should be performed as often as necessary, but as infrequently as possible. Vaccines should be brought to room temperature prior to administration and injected at sites in which FISS surgery would likely be curative; the interscapular region should be avoided. Post-vaccinal monitoring is essential.